The global In Vitro Diagnostic (IVD) Quality Control Market is poised for significant growth, fueled by advancements in diagnostic technology, increasing demand for accurate testing, and a growing emphasis on healthcare quality and patient safety. This market segment plays a pivotal role in ensuring the reliability and precision of diagnostic tests, making it an indispensable component of the healthcare industry.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582
global IVD quality control market is projected to reach USD 1.6 billion by 2027 from USD 1.3 billion in 2022, at a CAGR of 5.4% during the forecast period. The IVD quality control market is mainly driven by the increasing demand for laboratory accreditations and accredited laboratories.
Several factors are contributing to this upward trajectory, including:
Advancements in Diagnostic Technologies: The constant evolution of diagnostic technologies, such as PCR, immunoassays, and next-generation sequencing, is driving the demand for high-quality control materials to ensure the accuracy and reliability of test results.
Rising Chronic Disease Prevalence: The increasing prevalence of chronic diseases, infectious diseases, and cancer is boosting the demand for diagnostic tests. Accurate and consistent test results are crucial for early detection and disease management.
Stringent Regulatory Guidelines: Regulatory bodies around the world are placing greater emphasis on the quality and accuracy of diagnostic tests. This has led to increased adoption of quality control materials and processes by laboratories and diagnostic manufacturers.
Focus on Patient Safety: Healthcare providers are prioritizing patient safety and outcomes. IVD quality control plays a vital role in minimizing errors, reducing misdiagnoses, and enhancing overall patient care.
In response to these trends, market leaders and innovative startups are continually developing and launching new quality control solutions. These include ready-to-use quality control materials, software solutions for data analysis, and customized quality assurance programs tailored to specific diagnostic tests and instruments.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582
Key Market Players
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).
Bio-Rad Laboratories, Inc. holds the leading position in the IVD quality control market. The company provides innovative quality control products and services. It also offers a range of third-party quality controls, data management solutions, and external quality assurance services for hospital laboratories, reference laboratories, transfusion laboratories, and physician office laboratories.
Thermo Fisher Scientific Inc. is ranked second in the world for IVD quality control. The company is a top supplier of IVD quality control goods and services. Clinical chemistry, molecular control, microbiology, serology, serum toxicity testing, specimen validity testing, and therapeutic medication monitoring are among the wide range of quality controls that the company offers.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=198032582
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States